Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Perioperative interventions to decrease transfusion of allogeneic blood products

M H Ereth1, W C Oliver, P J Santrach

  • 1Department of Anesthesiology, Mayo Clinic Rochester, MN 55905.

Mayo Clinic Proceedings
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Healthcare-associated infection impact with bioaerosol treatment and COVID-19 mitigation measures.

The Journal of hospital infection·2021
Same author

The effect of in vitro recombinant factor VIIA on coagulation parameters for blood taken during liver transplantation.

Transplantation proceedings·2006
Same author

Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.

Journal of cardiothoracic and vascular anesthesia·2003
Same author

Comparison of LightCycler PCR, rapid antigen immunoassay, and culture for detection of group A streptococci from throat swabs.

Journal of clinical microbiology·2003
Same author

Biocompatibility of Trillium Biopassive Surface-coated oxygenator versus uncoated oxygenator during cardiopulmonary bypass.

Journal of cardiothoracic and vascular anesthesia·2001
Same author

Thirty-day mortality after elective total hip arthroplasty.

The Journal of bone and joint surgery. American volume·2001
Same journal

37-Year-Old Woman With Jaundice.

Mayo Clinic proceedings·2026
Same journal

34-Year-Old Woman With An Unidentified Overdose.

Mayo Clinic proceedings·2026
Same journal

Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety.

Mayo Clinic proceedings·2026
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
Same journal

Chronic Kidney Disease-In the Limelight, July 2026.

Mayo Clinic proceedings·2026
See all related articles

Strategies to reduce allogeneic blood transfusions are crucial for patient safety. Options include autologous blood collection and pharmacologic agents to manage perioperative bleeding and coagulopathy.

Area of Science:

  • Anesthesiology
  • Transfusion Medicine
  • Surgical Patient Management

Background:

  • Allogeneic blood transfusions carry risks, including transfusion-related morbidity.
  • There is a growing need for strategies to minimize exposure to allogeneic blood products.

Purpose of the Study:

  • To review available options for decreasing perioperative transfusion of allogeneic blood products.
  • To discuss the development of individualized transfusion strategies.

Main Methods:

  • Review of current literature and clinical practices.
  • Focus on patient-specific factors: preexisting conditions, physiological needs, perioperative stress, and coagulation status.

Main Results:

  • Autologous blood donation and perioperative collection reduce allogeneic exposure.

Related Experiment Videos

  • Pharmacologic agents like antifibrinolytics can decrease transfusion requirements.
  • Perioperative coagulation tests aid in diagnosing and managing bleeding disorders.

    • Conclusions:

    • Physicians have a better understanding of transfusion risks and benefits.
    • Conservative and scientific approaches are now favored for managing perioperative bleeding and coagulopathy.